Moon Surgical has received clearance from the US Food and Drug Administration (FDA) for the commercial version of its Maestro surgical system.
The company previously received FDA clearance for a non-commercial version of the system in September 2022. In September 2023, Maestro was used to assist in weight loss surgery procedures in the US.
In addition to its surgical assistance capabilities, Maestro is equipped with the edge computing platform NVIDIA Holoscan, which enables real-time algorithms based on AI to be deployed in the operating room for immediate benefits during surgery.
